Inhibitor Therapeutics, Inc. Current State and Local Tax Expense (Benefit)
Inhibitor Therapeutics, Inc. (INTI) reported Current State and Local Tax Expense (Benefit) of $32.26 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2024-03-29
- Inhibitor Therapeutics, Inc. current state and local tax expense (benefit) for fiscal 2022 was $32.26K.
| Period end | Current State and Local Tax Expense (Benefit) 12 month |
|---|---|
| 2022-12-31 | $32.26K 10-K · filed 2024-03-29 |